By Jesse Scheckner | Florida Politics

Members of the House Health and Human Services Committee heard from a panel of experts on their thoughts about pharmacy benefit managers and the power they have over prices, access to prescription drugs and the businesses that purvey them.

To their supporters, the colossal size of the industry’s more dominant pharmacy benefit managers is an asset. Detractors say it’s turned them into an oligopoly.

Known commonly as PBMs, pharmacy benefit managers are third-party administrators that represent insurers and negotiate with drug manufacturers.

Read More